CBX2 anticorps (N-Term)
-
- Antigène Voir toutes CBX2 Anticorps
- CBX2 (Chromobox Homolog 2 (CBX2))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CBX2 est non-conjugé
-
Application
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Specificité
- This antibody reacts to CBX2.
- Réactivité croisée (Details)
- Species reactivity (tested):Human.
- Purification
- Affinity chromatography on Protein A
- Immunogène
- KLH conjugated synthetic peptide selected from the N-terminal region of human CBX2
- Isotype
- Ig Fraction
- Top Product
- Discover our top product CBX2 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.25 mg/mL
- Buffer
- PBS, 0.09 % (W/V) sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freezing and thawing.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Antigène
- CBX2 (Chromobox Homolog 2 (CBX2))
- Autre désignation
- CBX2 (CBX2 Produits)
- Synonymes
- anticorps cbx2, anticorps M33, anticorps pc1, anticorps wu:fd20e09, anticorps zgc:103563, anticorps MOD2, anticorps pc, anticorps CDCA6, anticorps SRXY5, anticorps cdca6, anticorps m33, anticorps chromobox 2, anticorps chromobox homolog 2 (Drosophila Pc class), anticorps chromobox 2 L homeolog, anticorps cbx2, anticorps CBX2, anticorps Cbx2, anticorps cbx2.L
- Sujet
- CBX2 is a component of the polycomb multiprotein complex, which is required to maintain the transcriptionally repressive state of many genes throughout development via chromatin remodeling and modification of histones.Synonyms: Chromobox protein homolog 2
- Poids moléculaire
- 56081 Da
- ID gène
- 84733
- NCBI Accession
- NP_005180
-